CORRELATION OF DIASTOLIC BLOOD PRESSURE WITH HIGH SENSITIVITY C- REACTIVE PROTEIN IN MIDDLE AGED CORONARY HEART DISEASE PATIENTS

Main Article Content

Dr Sadia Islam
Dr Fida Muhammad
Dr Abdul Sadiq
Dr Bushra Aslam
Dr Ayesha Khan
Dr Sobia Khan Nabeel
Noor ul Huda
Maira Arshad
Rida Fatima

Keywords

Blood pressure, Diastolic, Patients, Biomarkers, Inflammatory

Abstract

Introduction: Coronary heart disease (CHD) remains one of the leading causes of morbidity and mortality worldwide, particularly affecting middle-aged individuals. This study aims to explore the correlation between diastolic blood pressure and high-sensitivity C-reactive protein levels in middle-aged patients with coronary heart disease.


Methodology: This cross-sectional study was conducted at Rashid Latif Medical College, Lahore during June 2023 to January 2024. The study involved a sample of 320 patients diagnosed with CHD, recruited from a cardiology clinic. Patients aged 40-60 years, diagnosed with CHD, and willing to provide informed consent were included in the study. A comprehensive medical history was obtained from each patient, including demographic information, lifestyle factors, and clinical history related to CHD. Blood pressure measurements were taken using a calibrated sphygmomanometer.


Results: The study involved 320 middle-aged patients with coronary heart disease (CHD). The mean diastolic blood pressure (DBP) among the participants was 85.2 ± 10.4 mmHg, while the mean serum high-sensitivity C-reactive protein (hs-CRP) level was 3.8 ± 1.6 mg/L. A Pearson’s correlation analysis was conducted to explore the relationship between DBP and hs-CRP levels. The analysis revealed a moderate positive correlation between DBP and hs-CRP levels (r = 0.45, p < 0.001), suggesting that higher DBP is associated with higher levels of hs-CRP.


Conclusion: There is a significant association between diastolic blood pressure and high-sensitivity C-reactive protein levels in middle-aged patients with coronary heart disease

Abstract 339 | pdf Downloads 51

References

1. Pan, L., Li, G., Wan, S. et al. The association between high-sensitivity C-reactive protein and blood pressure in Yi people. BMC Public Health 19, 991 (2019). https://doi.org/10.1186/s12889-019-7324-x
2. Ebong IA, Schreiner P, Lewis CE, Appiah D, Ghelani A, Wellons M. The association between high-sensitivity C-reactive protein and hypertension in women of the CARDIA study. Menopause. 2016;23(6):662–8.
3. Tangvarasittichai S, Pingmuanglaew P, Tangvarasittichai O. Association of Elevated Serum Lipoprotein(a), inflammation, oxidative stress and chronic kidney disease with hypertension in non-diabetes hypertensive patients. Indian J Clin Biochem. 2016;31(4):446–51.
4. Haleem, N., Zahra, M., Awan, A. N., Abbasi, S., Taimur, A., & Khan, M. (2024). CORRELATION OF DIASTOLIC BLOOD PRESSURE WITH HIGH SENSITIVITY C-REACTIVE PROTEIN IN MIDDLE AGED CORONARY HEART DISEASE PATIENTS. Pakistan Journal of Physiology, 20(2), 3-7.
5. Liu, Y., Yao, Y., Tang, X. F., Xu, N., Jiang, L., Gao, Z., ... & Yuan, J. Q. (2020). Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention. Journal of Cardiology, 75(1), 60-65.
6. Bisaria, S., Terrigno, V., Hunter, K., & Roy, S. (2020). Association of elevated levels of inflammatory marker high-sensitivity C-reactive protein and hypertension. Journal of Primary Care & Community Health, 11, 2150132720984426.
7. He, L., Fan, C., & Li, G. (2022). The relationship between serum C-reactive protein and senile hypertension. BMC Cardiovascular Disorders, 22(1), 500.
8. Nafari, A., Mohammadifard, N., Haghighatdoost, F., Nasirian, S., Najafian, J., Sadeghi, M., ... & Sarrafzadegan, N. (2022). High-sensitivity C-reactive protein and low-density lipoprotein cholesterol association with incident of cardiovascular events: Isfahan cohort study. BMC Cardiovascular Disorders, 22(1), 241.
9. Kelesoglu, S., Yilmaz, Y., & Elcık, D. (2021). Relationship between C-reactive protein to albumin ratio and coronary collateral circulation in patients with stable coronary artery disease. Angiology, 72(9), 829-835.
10. Burger, P. M., Koudstaal, S., Mosterd, A., Fiolet, A. T., Teraa, M., van der Meer, M. G., ... & Dorresteijn, J. A. (2023). C-reactive protein and risk of incident heart failure in patients with cardiovascular disease. Journal of the American College of Cardiology, 82(5), 414-426.
11. Yang, X., Yang, X., Yang, J., Wen, X., Wu, S., & Cui, L. (2023). High levels of high-sensitivity C reactive protein to albumin ratio can increase the risk of cardiovascular disease. J Epidemiol Community Health, 77(11), 721-727.
12. Tanaka, M., Imano, H., Kubota, Y., Yamagishi, K., Umesawa, M., Muraki, I., ... & Circs Investigators. (2021). Serum high-sensitivity C-reactive protein levels and the risk of atrial fibrillation in Japanese population: the circulatory risk in communities study. Journal of Atherosclerosis and Thrombosis, 28(2), 194-202.
13. Pellicori, P., Zhang, J., Cuthbert, J., Urbinati, A., Shah, P., Kazmi, S., ... & Cleland, J. G. (2020). High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovascular Research, 116(1), 91-100.
14. Koosha, P., Roohafza, H., Sarrafzadegan, N., Vakhshoori, M., Talaei, M., Sheikhbahaei, E., & Sadeghi, M. (2020). High sensitivity C-reactive protein predictive value for cardiovascular disease: a nested case control from Isfahan cohort study (ICS). Global Heart, 15(1).
15. Feng, G., Yang, M., Xu, L., Liu, Y., Yu, J., Zang, Y., ... & Zheng, X. (2023). Combined effects of high sensitivity C-reactive protein and triglyceride–glucose index on risk of cardiovascular disease among middle-aged and older Chinese: Evidence from the China Health and Retirement Longitudinal Study. Nutrition, Metabolism and Cardiovascular Diseases, 33(6), 1245-1253.
16. Chevli, P. A., Islam, T., Pokharel, Y., Rodriguez, F., Virani, S. S., Blaha, M. J., ... & Shapiro, M. D. (2022). Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of clinical lipidology, 16(6), 870-877.
17. Quispe, R., Michos, E. D., Martin, S. S., Puri, R., Toth, P. P., Al Suwaidi, J., ... & Elshazly, M. B. (2020). High‐Sensitivity C‐Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study. Journal of the American Heart Association, 9(3), e013600.

Most read articles by the same author(s)

<< < 1 2